text:
EX-99.2
4
ex99-2.htm
Corrected
Press Release: Tauriga Sciences, Inc. Sells Majority Stake of Pilus Energy Subsidiary to Open Therapeutics LLC
December
28, 2016 - New York, NY - Tauriga Sciences, Inc. (OTC PINK CURRENT TIER: TAUG) ("Tauriga" or the "Company"),
a company engaged in building businesses in the life sciences space, today announced it is issuing a material correction to its
press release dated December 27, 2016 which was titled "Tauriga Science Inc. Sells Majority Stake of Pilus Energy Subsidiary
to Open Therapeutics, LLC" (the "Initial Press Release") due to inaccurate numbers relating to the warrants
described therein. Specifically, and as defined below, Open Therapeutics directly owned warrants to purchase 28,917,647 shares
of the Company's common stock rather than 77,303,529. As such, only 23,134,118 warrants rather than 61,842,119 warrants
were cancelled as part of the transaction. Accordingly, the number of warrants held directly by Open Therapeutics to purchase
shares of the Company's stock is 5,783,520; which is less than the 15,406,706 warrants previously mentioned in the Initial
Press Release. The error was a result of the Company including certain warrants issued directly to equity holders of Pilus Energy
rather than only the warrants issued to Open Therapeutics. The Initial Press Release is replaced in its entirety as set forth
below:
Tauriga
Sciences, Inc. (OTC PINK CURRENT TIER: TAUG) ("Tauriga" or the "Company"), a company engaged in building
businesses in the life sciences space, today announced that it has sold an 80% majority stake in its wholly-owned subsidiary,
Pilus Energy LLC ("Pilus Energy"), to an Ohio-based company, Open Therapeutics LLC ("Open Therapeutics").
In consideration for this 80% interest, Open Therapeutics agreed to terminate and cancel 80% of the unexercised portion of the
warrant to purchase 28,917,647 shares of the Company's common stock issued on January 28, 2014 and more fully described
in the Form 8-K's filed by the Company with the Securities Exchange Commission on November 27, 2013 and February 4, 2014.
As such, only 5,783,520 shares of common stock remain subject to the warrant. Open Therapeutics was previously known as both Bacterial
Robotics, LLC and Microbial Robotics, LLC prior to its name change to Open Therapeutics on May 12, 2016.
Open
Therapeutics plans to continue the development of Pilus Energy's proprietary technology with the ultimate goal of commercialization.
Open Therapeutics also agreed Pilus Energy would pay to Tauriga 20% of the net profit generated from Pilus Energy, if any, for
each calendar year (or portion thereof) beginning January 1, 2017 ("Profit Sharing Payment"). The Tauriga Profit Sharing
Payment will be calculated and paid once per calendar year for the preceding calendar year once Open Therapeutics' financial
statements for such preceding calendar year are finalized by its accountants. However, Tauriga agreed that the first $75,000 owed
to the Company under the Profit Sharing Payment shall be retained by Open Therapeutics unless other payment arrangements are reached.
Tauriga's
CEO Seth M. Shaw expressed, "The Company is pleased to have reached this agreement with Open Therapeutics to potentially
retain some long term value for its shareholders should Pilus Energy ultimately be successful in commercializing its technology.
Open Therapeutics' CEO, Mr. Jerome Hamilton, has a vision to continue the commercialization process for Pilus Energy. Tauriga's
management intends to be both cooperative and helpful in those mutually beneficial efforts. Lastly and as previously disclosed,
the Company believes the actions of Cowan Gunteski significantly damaged Tauriga's efforts to create shareholder value with
respect to Pilus Energy. The Company expects to assert such damages in its ongoing litigation against Cowan Gunteski".
ABOUT
TAURIGA SCIENCES, INC.
Tauirga
Sciences, Inc. (OTC PINK CURRENT TIER: TAUG) is a fully reporting life sciences company engaged in the development, marketing,
distribution and potential licensing of a broad array of products and technologies that may help individuals who are affected
by muscle tension. The Company has already identified potential products and technologies of interest and is actively working
towards the goal of creating an innovative product line to launch the business activities of ColluMauxil Therapeutics LLC (The
Company's previously announced new planned wholly owned subsidiary). The Company believes that one of its most important
strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends
to capitalize on distribution opportunities and will continually update shareholders on such developments. The Company is also
prosecuting its ongoing malpractice lawsuit against its predecessor audit firm, for which it's seeking monetary damages
in excess of $4,000,000 USD.
ABOUT
OPEN THERAPEUTICS™ LLC
Open
Therapeutics™ is a seven-year-old company that curates and develops open medical, biopharma, and synthetic biology-based
biotechnologies. Among the technologies being freely opened to the global community are essential proteins for developing antibiotic
and anticancer therapeutics, immunotherapy and oncolytics, and biomarker inducers. The Company is headquartered in Cincinnati,
Ohio with laboratory operations in Covington, Kentucky, USA, and Madrid, Spain via its strategic partner, Bacmine SL (
www.bacmine.com
).
For additional information, please visit Open Therapeutics' website at
http://opentherapeutics.org/about-us/
.
NON
SOLICITATION:
This
press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there
be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.
Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and
will be offered pursuant to an exemption from registration.
DISCLAIMERS:
This
press release contains information about Open Therapeutics, its business, products and other information contained on Open Therapeutics'
website. Tauriga is not responsible for this information, the accuracy of it, or the content of the information on Open Therapeutics'
website.
Forward-Looking
Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements"
as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation: expectations, expects, anticipates,
believes, hopes, beliefs, plans and objectives regarding the development, use and marketability of products as well as the attainment
of certain corporate goals and milestones (i.e. SEC Periodic Filings, Filing of Proxies, etc). Such forward-looking statements
are based on present circumstances and on Tauriga's predictions with respect to events that have not occurred, that may
not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking
statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results
and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results
expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability
to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other
factors over which Tauriga has little or no control. Such forward-looking statements are made only as of the date of this release,
and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers
should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents
filed from time to time by Tauriga with the Securities and Exchange Commission. This press release does not and shall not constitute
an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities,
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended
(the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration,
or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
Contact:
Tauriga
Sciences, Inc.
Mr.
Seth Shaw
Chief
Executive Officer
Tel:
1-917-796-9926
Email:
sshaw@tauriga.com
SOURCE:
Tauriga Sciences, Inc.

text: Tauriga Sciences, Inc.

text: Pilus Energy Subsidiary

text: Open Therapeutics LLC

text: Tauriga Sciences, Inc.

text: Tauriga Science Inc.

text: Pilus Energy Subsidiary

text: Open Therapeutics, LLC

text:
Tauriga
Sciences, Inc.

text: Therapeutics LLC

text: Jerome Hamilton

text: TAURIGA SCIENCES, INC.

text: Therapeutics LLC

text:
Tauriga
Sciences, Inc.

text: Seth Shaw

text: Tauriga Sciences, Inc.


dataset: buster

text:
EX-99.1
4
a08-3234_1ex99d1.htm
EX-99.1
Exhibit 99.1
News
Release
Buckeye Partners, L.P.
Five TEK Park
9999 Hamilton Blvd.
Breinigsville,
PA 18031
NYSE: BPL
Contact:
Stephen
R. Milbourne,
08-02
Manager,
Investor Relations
smilbourne@buckeye.com
(800)
422-2825
BUCKEYE PARTNERS, L.P. ACQUIRES
NORTHERN CALIFORNIA NATURAL GAS STORAGE FACILITY
Breinigsville,
PA - January 18, 2008... Buckeye Partners, L.P. (NYSE:BPL) (the "Partnership"),
today announced that the Partnership had closed on its previously announced
acquisition of Lodi Gas Storage, L.L.C. which owns a natural gas storage
facility located in northern California, from an affiliate of ArcLight Capital
Partners, LLC ("ArcLight") for total cash consideration of approximately $432
million. Additional consideration of $12
million will be due to ArcLight upon receipt of approval from the California
Public Utilities Commission for a storage reservoir expansion project
associated with the acquired assets, known as Kirby Hills Phase II. The Partnership financed the purchase price
through public equity offerings completed in August, 2007 and December, 2007,
and a public debt offering completed earlier this month.
Lodi
Gas Storage owns and operates a storage facility located near Lodi, California,
and a facility known as Kirby Hills located approximately 45 miles west of the
Lodi facility. The combined LGS
facilities provide approximately 22 Bcf of working gas capacity and are
connected to Pacific Gas and Electric's intrastate gas pipelines that serve
natural gas demand in the San Francisco and Sacramento areas. The Kirby Hills Phase II expansion project is
expected to provide an approximate incremental 12 Bcf of working gas
capacity. The expansion project is
expected to be in service by the end of 2008.
Buckeye
Partners, L.P., through its operating subsidiaries, owns and operates one of
the largest independent refined petroleum products pipeline systems in the
United States in terms of volumes delivered, with approximately 5,400 miles of
pipeline. The
(more)
Partnership also owns or operates
51 refined petroleum products terminals with an aggregate storage capacity of
approximately 20.0 million barrels in Illinois, Indiana, Massachusetts,
Michigan, Missouri, New York, Ohio, Pennsylvania and Wisconsin, and operates
and maintains approximately 2,700 miles of pipeline under agreements with major
oil and chemical companies. For more
information about Buckeye Partners, L.P., visit the Partnership's website at
www.buckeye.com.
* * * * *
This press release includes forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934 that the General
Partner believes to be reasonable as of today's date. Actual results may differ significantly because
of risks and uncertainties that are difficult to predict and many of which are
beyond the control of the Partnership.
Among them are (1) adverse weather conditions resulting in reduced
demand; (2) changes in rate regulation by the Federal Energy Regulatory
Commission; (3) changes in other laws and regulations, including safety,
tax and accounting matters; (4) competitive pressures from other
transportation services and alternative energy sources; (5) liability for
environmental claims; (6) improvements in energy efficiency and technology
resulting in reduced demand; (7) the inability to integrate acquired
assets successfully with the Partnership's existing assets and to realize
anticipated cost savings and other efficiencies; (8) labor relations; (9) changes
in real property tax assessments; (10) regional economic conditions; (11)
market prices of petroleum products and the demand for those products in the
Partnership's service territory; (12) disruptions to the air travel system;
(13) security issues relating to the Partnership's assets; (14) interest rate
fluctuations and other capital market conditions; (15) construction costs,
unanticipated capital expenditures and operating expenses to repair or replace
the Partnership's assets; (16) availability and cost of insurance on the
Partnership's assets and operations; (17) expansion in the operations of the
Partnership's competitors; (18) shut-downs or cutbacks at major refineries that
use the Partnership's services; and (19) the treatment of the Partnership as a
corporation for federal income tax purposes or if the Partnership becomes
subject to entity-level taxation for state tax purposes. You should read the Partnership's Annual
Report on Form 10-K, and its most recently filed Form 10-Q, for a
more extensive list of factors that could affect results. The Partnership
undertakes no obligation to revise its forward-looking statements to reflect
events or circumstances occurring after today's date.
2

label: organization

text: Buckeye Partners, L.P.

override: organization

text: BUCKEYE PARTNERS, L.P.

text: Buckeye Partners, L.P.

text: Lodi Gas Storage, L.L.C.

text:
Buckeye
Partners, L.P.

text: Buckeye Partners, L.P.

source_dataset: expertai/BUSTER

annotation_scope: BUSTER company-role spans plus reviewed organization, fund, person, and event additions with document-local surface projection; annotations remain non-exhaustive


text:
EX-99.1
2
pcsv090913ex99_1.htm
EX-99.1
PCS Edventures, Inc.
345 Bobwhite Ct. Suite 200
Boise, ID 83706
(800) 429-3110
http://www.edventures.com
PCS
Announces Subsidiary Sale
BOISE, Idaho - September 9,
2013 - PCS Edventures!.com, Inc., (PCSV) a leading provider of K-12 programs focused on Science, Technology, Engineering
and Mathematics (STEM) today announced the sale of its Labmentors Canadian subsidiary to JAK, Ltd., a Canadian company, for $150,000
to be through the assumption of liabilities and a long term promissory note.
Labmentors provides guided, on-line
labs for web-based information technology training and certification servicing customers such as Devry and Cengage. PCS acquired
the subsidiary in November of 2005.
Robert Grover, PCS CEO, said "We
have enjoyed the relationship with Labmentors and look forward to continuing to work closely with them on future projects that
may be mutually beneficial. We are confident that the continued narrowing of our focus on K12 STEM and PCS Robotics programs is
the optimum path for our company".
Joseph Khoury, President of Labmentors
and CEO of JAK, Ltd., said "Labmentors has big plans for refining our business model and taking our lab certification programs
to the next level. We have benefitted from the long term relationship with PCS and will look forward to pursuing joint opportunities
with them in the future should they arise".
The transaction will strengthen the
PCS balance sheet through the elimination of nearly $100,000 in liabilities as well as streamline internal operations and accounting
processes.
To learn more about PCSV visit https://www.edventures.com/investors
About PCS Edventures!
PCS Edventures!.com,
Inc. (PCS) designs and delivers educational products
and services
to the K-12 market that develop 21st century skills. PCS programs
emphasize
hands-on experiences in Science, Technology, Engineering and
Math (STEM)
and have been deployed at over 7,000 sites in all 50 United
States and
17 foreign countries. Additional information on our products is available at
http://www.edventures.com.
PCS Edventures, headquartered in Boise, Idaho, is listed
on the OTC Markets
(OTCQB) under the symbol "PCSV".
_ _
This press release contains forward-looking
statements within the meaning of
Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Act
of 1934, actual results could differ
materially from such statements.
Contact Information:
Financial Contact: Shannon Hull 1.800.429.3110,
Shannon@edventures.com
Investor Contact: Jolene Anderson
1.800.429.3110, Jolene@edventures.com
Investor Relations Web Site: www.edventures.com/investors
2

text: PCS

text: PCS Edventures!.com, Inc.

text: Labmentors

text: JAK, Ltd.

text: Labmentors

text: PCS

text: PCS

text: Labmentors

text: PCS

label: person

text: Joseph Khoury

text: Labmentors

text: JAK, Ltd.

text: Labmentors

text: PCS

text: PCS

text:
PCS Edventures!.com,
Inc.

text: PCS

text: PCS


text:
EX-99.1
4
v023733_ex99-1.txt
EXHIBIT 99.1
[GRAPHIC OMITTED]
FOR MORE INFORMATION CONTACT:
PUBLIC RELATIONS:
Ilya Welfeld
201-439-1010
ilya@roomlinx.com
Investor Relations
THOMAS J. ROZYCKI, JR.
CUBITT JACOBS & PROSEK
212-279-3115 X208
TOM@CJPCOM.COM
ROOMLINX COMPLETES ACQUISITION OF SUITESPEED
Combined Company Will Service 200 Hotels Representing More than 35,000
Rooms Nationwide
HACKENSACK, NEW JERSEY (AUGUST 10, 2005) -RoomLinX, Inc. (OTCBB: RMLX.OB), a
leading provider of wireless high-speed network solutions to the hospitality
industry, today announced that it has completed the acquisition of SuiteSpeed,
Inc., a leading provider of wireless solutions for hotels. Customers will
experience no disruption in service, and their company contact points will
remain unchanged. Pursuant to the merger agreement, RoomLinX will issue
21,450,000 shares of its common stock to acquire the outstanding stock of
SuiteSpeed and an additional 6,183,870 shares of its common stock to cancel
certain indebtedness owed by SuiteSpeed. The 21,450,000 shares have piggy-back
registration rights under certain circumstances".
"Since we first announced our intention to acquire SuiteSpeed in the spring, we
have had the pleasure of getting to know the company, its management and its
customers", said Aaron Dobrinsky, CEO of RoomLinX. "It was extremely encouraging
to emerge from the due diligence period with the belief that the planned
acquisition promised even greater synergies and potential than initially
thought. As we have indicated, the addition of SuiteSpeed should enhance our
leadership position in the industry with more rooms under management, increased
recurring revenue, economies of scale, increased offerings and a superior
executive in Mike Wasik, formerly CEO of SuiteSpeed".
SuiteSpeed, a provider of high-speed wireless Internet access solutions, has
delivered WiFi services to hotels since 2000. The company serves brand-name
properties such as the Renaissance, Courtyard by Marriott, Holiday Inn,
Radisson, Hampton Inn and Best Western.
"We have been looking forward to the closing of this acquisition and I
personally am very pleased to be joining RoomLinX as Executive Vice President"
said Mike Wasik, founder of SuiteSpeed. "Plans for the acquisition have been
well received by interested parties on both sides of the transaction and we
believe the benefits to customers will be immediately apparent".
ABOUT ROOMLINX, INC.
RoomLinX is a pioneer in Broadband High Speed Wireless Internet connectivity,
specializing in providing advanced WI-FI Wireless and Wired networking solutions
for High Speed Internet access to Hotel Guests, Convention Center Exhibitors,
Corporate Apartments, and Special Event participants. Designing, deploying and
servicing site-specific wireless networks for the hospitality industry is
RoomLinX's core competency.
# # #
THE STATEMENTS CONTAINED IN THIS PRESS RELEASE OF ROOMLINX, INC. (THE "COMPANY")
THAT ARE NOT BASED ON HISTORICAL FACT ARE "FORWARD-LOOKING STATEMENTS". SUCH
FORWARD-LOOKING STATEMENTS (INCLUDING THE STATEMENTS REGARDING THE POTENTIAL
BENEFITS FROM THE ACQUISITION) INVOLVE RISKS AND UNCERTAINTIES, INCLUDING BUT
NOT LIMITED TO: (I) THE COMPANY'S HISTORY OF UNPROFITABLE OPERATIONS, BOTH WITH
RESPECT TO ITS CORE BUSINESS AND THE BUSINESS PREVIOUSLY PERFORMED BY ARC
COMMUNICATIONS, (II) THE SIGNIFICANT OPERATING LOSSES THAT THE COMPANY HAS
INCURRED TO DATE, (III) THE COMPANY'S LACK OF LIQUIDITY AND NEED FOR ADDITIONAL
CAPITAL WHICH IT MAY NOT BE ABLE TO OBTAIN ON FAVORABLE TERMS OR AT ALL, (IV)
THE "GOING CONCERN" QUALIFICATIONS THAT ACCOMPANIES THE COMPANY'S FINANCIAL
STATEMENTS, WHICH, AMONG OTHER THINGS, MAY MAKE IT MORE DIFFICULT FOR THE
COMPANY TO RAISE THE ADDITIONAL CAPITAL THAT IT REQUIRES IN ORDER TO REMAIN IN
BUSINESS, (V) THE FACT THAT THE COMPANY HAS BEEN REQUIRED TO OPERATE WITH A
WORKING CAPITAL DEFICIT, WHICH LIMITS ITS OPERATING FLEXIBILITY AND
OPPORTUNITIES, (VI) THE SUBSTANTIALLY GREATER RESOURCES AVAILABLE TO MANY OF THE
COMPANY'S COMPETITORS, (VII) THE COMPANY'S EXPECTATION THAT IT WILL CONTINUE TO
OPERATE AT A LOSS FOR THE FORESEEABLE FUTURE, (VIII) THE FACT THAT THE COMPANY'S
LACK OF CAPITAL SUBSTANTIALLY RESTRICTS ITS FLEXIBILITY AND OPPORTUNITY TO
INCREASE ITS REVENUES, (IX) THE IMPORTANCE TO THE COMPANY THAT ITS OFFERINGS
REMAIN TECHNOLOGICALLY ADVANCED IF THE COMPANY IS TO ATTRACT NEW CUSTOMERS AND
MAINTAIN EXISTING CUSTOMERS, (X) THE COMPANY'S DEPENDENCE ON CERTAIN KEY
EMPLOYEES AND KEY SUPPLIERS, (XI) RISKS ASSOCIATED WITH POTENTIAL INTELLECTUAL
PROPERTY CLAIMS, (XII) THE IMPACT ON THE COMPANY'S BUSINESS AND INDUSTRY OF
GENERAL ECONOMIC CONDITIONS AND REGULATORY DEVELOPMENTS AND (XIII) RISKS
ASSOCIATED DIRECTLY WITH THE BUSINESS COMBINATION, INCLUDING WITHOUT LIMITATION
(A) THE POSSIBILITY THAT THE BENEFITS ANTICIPATED FROM THE TRANSACTION ARE NOT
REALIZED AND (B) RISKS ASSOCIATED WITH INTEGRATING TWO SEPARATE BUSINESSES. SUCH
RISKS AND OTHERS ARE AND SHALL BE MORE FULLY DESCRIBED IN THE "RISK FACTORS" SET
FORTH IN THE COMPANY'S FILINGS WITH THE SECURITIES AND EXCHANGE COMMISSION. THE
COMPANY'S ACTUAL RESULTS COULD DIFFER MATERIALLY FROM THE RESULTS EXPRESSED IN,
OR IMPLIED BY, SUCH FORWARD-LOOKING STATEMENTS.
-2-

text: ROOMLINX

text: SUITESPEED

text: RoomLinX, Inc.

text:
SuiteSpeed,
Inc.

text: RoomLinX

text: SuiteSpeed

text: SuiteSpeed

text: SuiteSpeed

text: Aaron Dobrinsky

text: RoomLinX

text: SuiteSpeed

text: Mike Wasik

text: SuiteSpeed

text: SuiteSpeed

text: RoomLinX

text: Mike Wasik

text: SuiteSpeed

text: ROOMLINX, INC.

text: RoomLinX

text: RoomLinX

text: ROOMLINX, INC.


text:
EX-99.1
4
f54377exv99w1.htm
EX-99.1
exv99w1
Exhibit 99.1
Cavium Networks Contact:
Angel Atondo
Marketing Communications Manager
Tel: (650) 623-7033
Email: angel.atondo@caviumnetworks.com
Cavium Networks Completes Acquisition of MontaVista Software
MOUNTAIN VIEW, CA, December 18, 2009
- Cavium Networks (NASDAQ: CAVM), a leading provider of
highly integrated semiconductor products that enable intelligent processing for networking,
wireless, storage and video applications, today announced that they have completed their
acquisition of MontaVista Software, Inc., finalizing an agreement that was announced on November
10, 2009.
MontaVista Software is a leader in multi-core embedded Linux operating systems, virtualization,
development tools and professional services with a broad array of Tier-1 customers. Embedded
Linux is fast becoming the operating system of choice for hundreds of millions of devices ranging
from very large carrier grade equipment to consumer electronics. Traditionally embedded devices
used a proprietary OS or commercial real-time operating system. However, there is a major trend
towards using embedded Linux. This rapid adoption of Linux in embedded networking, wireless,
consumer electronics, mobile devices and storage is driving the demand for a high quality,
commercial grade embedded Linux along with support for multi-core processors and embedded
virtualization.
Software is becoming an increasingly important part of the total multi-core processor solution and
this acquisition will complement Cavium Network's broad portfolio of multi-core processors to
deliver more highly compelling, integrated and differentiated embedded solutions to the market.
The MontaVista brand name will continue to be used and MontaVista will maintain its own dedicated
and focused engineering, sales and product management staff along with supporting multiple
processor architectures from leading semiconductor vendors. MontaVista's customers and partners
will see no change in customer facing field operations and the web-based support and product
download sites will be maintained. Art Landro, previously Executive Vice President of MontaVista's
Worldwide Field Operations, has been appointed as the President of MontaVista Software. Prior to
joining MontaVista in 2007, Art Landro held Vice President positions at EMC Corporation,
Documentum, Cadence Design, and General DataComm.
About Cavium Networks
Cavium Networks is a leading provider of highly integrated semiconductor products that enable
intelligent processing in networking, communications, storage and video applications. Cavium
Networks offers a broad portfolio of integrated, software-compatible processors ranging in
performance from 10 Mbps to 40 Gbps that enable secure, intelligent functionality in enterprise,
data-center, broadband/consumer and access and service provider equipment. Cavium Networks
processors are supported by ecosystem partners that provide operating systems, tool support,
reference
designs and other services. Cavium Networks principal offices are in Mountain View, CA with design
team locations in California, Massachusetts, India and Taiwan. For more information, please visit:
http://www.caviumnetworks.com.
###
Note on Forward-Looking Statements
This press release contains forward-looking statements regarding future events that involve risks
and uncertainties. Words such as "will", "plans" and "expect" and similar expression are intended
to identify forward-looking statements. These forward-looking statements are based upon Cavium's
current expectations. Forward-looking statements involve risks and uncertainties, as well as
assumptions that if they do not fully materialize or prove incorrect, could cause our results to
differ materially from those expressed or implied by such forward-looking statements. The risks and
uncertainties that could cause our results to differ materially from those expressed or implied by
such forward-looking statements include but are not limited to technological advances; pricing
pressures; general economic conditions; development of new products and technologies; whether
Cavium is successful in marketing its products; the success of integrating MontaVista Software
products with Cavium's products and other risks and uncertainties described more fully in our
documents filed with or furnished to the Securities and Exchange Commission. More information about
these and other risks that may impact Cavium's business are set forth in the "Risk Factors" section
of Cavium's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on
November 3, 2009 and Cavium's Form 10-K filed with the Securities and Exchange Commission on March
2, 2009. Cavium expressly disclaims any obligation or undertaking to release publicly any updates
or revisions to any forward-looking statements contained herein.

text: Cavium Networks

text: Cavium Networks

text: MontaVista Software

text: Cavium Networks

text: MontaVista Software, Inc.

text: MontaVista Software

text: Cavium

text: MontaVista Software

text: Cavium Networks

text: Cavium Networks

text:
Cavium
Networks

text: Cavium Networks

text: Cavium Networks

text: Cavium

text: Cavium

text: MontaVista Software

text: Cavium

text: Cavium

text: Cavium

text: Cavium

text: Cavium


text:
EX-99.2
2
a2143359zex-99_2.htm
EX 99.2
QuickLinks
-- Click here to rapidly navigate through this document
Exhibit 99.2
CIBER, Inc.
5251 DTC Parkway, Suite 1400
Greenwood Village, CO 80111
www.ciber.com
For Immediate Release
Contacts:
Doug Eisenbrandt
Investor Relations
303-220-0100
deisenbrandt@ciber.com
Jenn Wing
Media Relations
303-220-0100
jwing@ciber.com
CIBER ANNOUNCES CLOSING NOVASOFT AG SHARES PURCHASE Acquires 67% of Net Shares Outstanding, Will Tender for the Balance
GREENWOOD VILLAGE, Colo.-September 10, 2004-CIBER, Inc. (NYSE: CBR) today announced the closing of its purchase for
67 percent of the net outstanding shares of Novasoft AG (FSE: NOVG.DE) effective September 10, 2004.
"We
are pleased to get this major step completed. The comments we have heard about Novasoft, both from inside and outside of SAP, their primary software partner, have been very
favorable. Further, communication between our employee groups has already started and has been positive as well", said Terje Laugerud, President CIBER Europe. "We will now begin the German process for
an authorized tender for the balance of Novasoft's shares, which we hope to accomplish in mid-October".
"We
have found CIBER to be very efficient and honorable in the process of partnering Novasoft with a larger, international player. We now look forward to growing our business together,"
said Georg Konrad, Co-Chief Executive Officer of Novasoft.
About CIBER, Inc.
CIBER, Inc. (NYSE: CBR) is a pure-play international system integration consultancy with superior value-priced services for both private and
government sector clients. CIBER's global delivery services are offered on a project or strategic staffing basis, in both custom and enterprise resource planning (ERP) package environments, and across
all technology platforms, operating systems and infrastructures. Founded in 1974, the company's consultants now serve client businesses from over 60 U.S. offices, 18 European offices and three offices
in Asia. With offices in 14 countries, annualized revenue run rate of approximately $925 million and approximately 8,000 employees, CIBER's IT specialists continuously build and upgrade our
clients' systems to "competitive advantage status." CIBER is included in the Russell 2000 Index and the S&P Small Cap 600 Index. CIBER, ALWAYS ABLE.
Forward-Looking and Cautionary Statements
Statements contained in this release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These
statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, as discussed in the
company's filings with the Securities and Exchange Commission. CIBER undertakes neither intention nor obligation to publicly update or revise any forward-looking statements. CIBER and the CIBER logo
are trademarks or registered trademarks of CIBER, Inc. Copyright© 2004. All rights reserved.
###
QuickLinks
CIBER ANNOUNCES CLOSING NOVASOFT AG SHARES PURCHASE Acquires 67% of Net Shares Outstanding, Will Tender for the Balance

text: CIBER, Inc.

text: CIBER

text: NOVASOFT AG

text: CIBER, Inc.

text: Novasoft AG

text: Terje Laugerud

text: CIBER

text: CIBER

text: CIBER, Inc.

text: CIBER, Inc.

text: CIBER

text: CIBER

text: CIBER

text: CIBER

text: CIBER

text: CIBER

text: CIBER

text: CIBER, Inc.

text: CIBER

text: NOVASOFT AG


text:
EX-99
2
exh_991.htm
EXHIBIT 99.1
EXHIBIT 99.1
WCA Waste Corporation Acquires Houston Area Landfill and Transfer Station
HOUSTON, June 29, 2007 (PRIME NEWSWIRE) -- WCA Waste Corporation (Nasdaq:WCAA) announces today that it has acquired the Ft. Bend Regional Landfill (a 2,664 acre and approximately 46 million cubic yard site currently providing 50 years of life without expansion), a transfer station, collection routes and other assets in Houston, Texas from Waste Services, Inc. for cash and the exchange of WCA Waste Corporation's hauling and transfer operations in the Ft. Myers, Florida market.
Tom Fatjo, Chairman of WCA Waste Corporation, states, "This exchange of assets positions our company with a substantial opportunity for growth, increased profitability and increased internalization in Houston, Texas. We are adding this large municipal solid waste landfill and a permitted and operating transfer station to our existing Houston platform of three operating construction and demolition landfills, two permitted to be constructed transfer stations and approximately one-hundred collection vehicles surrounding the Houston metropolitan area. To have this network of assets in Houston, Texas, the fourth largest city in the United States, allows us to take advantage of many tuck-in hauling acquisitions and municipal contract opportunities".
WCA exchanged $23.7 million in cash, a transfer station and hauling operations in Ft. Myers, Florida for the Ft. Bend Landfill, the transfer station, related hauling operations, and a $10.5 million non-interest bearing note receivable from Waste Services, Inc.
WCA Waste Corporation is an integrated company engaged in the transportation, processing and disposal of non-hazardous solid waste. The Company's operations consists of twenty-four landfills, twenty-four transfer stations/material recovery facilities and twenty-seven collection operations located throughout Alabama, Arkansas, Colorado, Florida, Kansas, Missouri, New Mexico, North Carolina, Oklahoma, South Carolina, Tennessee and Texas. The Company's common stock is traded on the NASDAQ National Market System under the symbol "WCAA".
The WCA Waste Corporation logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=1736
Safe Harbor for Forward-Looking Statements
This press release may contain statements that are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. From time to time, our public filings, press releases and other communications (such as conference calls and presentations) will contain forward-looking statements. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. This is true of our description of our acquisition strategy and our capital plan (and the effects of such strategy and plan) for example. Such statements include, but are not limited to, plans, objectives, expectations, intentions and other statements that are not historical facts.
All such statements are based upon the current beliefs and expectations of WCA's management and are subject to significant risks and uncertainties. Some of those risks and uncertainties have been more fully described in "Risk Factors and Cautionary Statement about Forward-Looking Statements" in WCA's Annual Report on Form 10-K with respect to the year ended December 31, 2006 and its Quarterly Report on Form 10-Q with respect to the quarterly period ending on March 31, 2007. Please consider these factors carefully in evaluating the forward-looking statements and do not place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
CONTACT: WCA Waste Corporation, Houston, Texas
Tommy Fatjo
713-292-2400

text: WCA Waste Corporation

text: WCA Waste Corporation

text: WCA Waste Corporation

text: Tom Fatjo

text: WCA Waste Corporation

text: WCA Waste Corporation

text: WCA Waste Corporation

text: WCA Waste Corporation


text:
EX-99.1
3
cbai_ex991.htm
PRESS RELEASE
cbai_ex991.htm
Exhibit 99.1
Cord Blood America, Inc. Announces Sale of Stake in stellacure, GmbH to Medivision
LAS VEGAS, October 2, 2012 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced that it has sold its 51% stake in its German subsidiary, stellacure GmbH ("stellacure") to Medivision mbH, headquartered in Hamburg, Germany ("Medivision"), for approximately 33,649 Euros or $43,420. A principal of Medivision was also a minority shareholder in stellacure prior to closure of this deal. Other minority shareholders, with the exception of the German Red Cross, agreed to sell their positions in stellacure to Medivision pro
rata
to the terms of CBAI.
"There were primarily three options facing us as we evaluated stellacure; we could continue to invest, we could sell our stake at a highly discounted position, or allow for a bankruptcy filing. Regarding further investment, we concluded several months ago that we were not going to provide any additional funding to stellacure, and in fact, have not provided any working capital under the terms of the loan agreement since September of 2011" commented Joseph Vicente, President of Cord Blood America. "There was no clear path regarding the additional time or incremental capital stellacure would require to achieve profitability. In our most recent 2012 second quarter filing, stellacure experienced a 28.3% decline in revenues compared to same period in 2011. Those revenues accounted for only 6.3% of the total consolidated revenues for the Company, and stellacure was the only operating unit to post an operating loss which totaled over $100,000. The capital needed to sustain the ongoing operating losses is much better served in our current debt restructuring initiatives
which we first announced in early July and continue to focus on as we improve the capital structure of the Company. In addition to the elimination of the consolidated operating loses, we expect save approximately $40,000 in annual professional service fees".
Mr. Vicente concluded, "With the decision made not to provide additional funding, we were faced with the imminent filing of bankruptcy if the business was not sold. With an interested party coming forward to acquire stellacure, we concluded that our ability to secure a waiver against all past and future claims, along with a nominal amount of cash, as the key factors resulting in our decision to sell our stake in stellacure. The protracted uncertainty surrounding a bankruptcy is something we wanted to avoid as we position CBAI for the future. Regarding the Company's financial statements, we are going to take a one time charge in our third quarter, 2012, as we write off a significant portion of the loan to stellacure. Going forward, we are confident we are a stronger company financially as we eliminate a subsidiary that we believe was not able to produce growth and/or profitability for the foreseeable future".
About Cord Blood America
Cord Blood America Inc. is the parent company of CorCell Companies, Inc. which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out about Cord Blood America, Inc. and CorCell Companies, Inc., visit our websites:
http://www.cordblood-america.com
/ for investor information and
http://www.corcell.com/
for customer information.
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate", "believe", "expect", "future", "intend", "plan", and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and Cord Blood America's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
Investor Contact:
Hayden IR
Cameron Donahue
Tel: 651-653-1854
Email: cameron@haydenir.com

text: Cord Blood America, Inc.

text: stellacure, GmbH

text: Medivision

text: Cord Blood America, Inc.

text: stellacure GmbH

text: Medivision mbH

text: Medivision

text: Medivision

text: Medivision

text: Joseph Vicente

text: Cord Blood America, Inc.


text:
EX-99.1
12
tm2023499d1_ex99-1.htm
EXHIBIT 99.1
Exhibit 99.1
Whole Earth
Brands, Inc. Announces Closing of Business Combination
Whole Earth
Brands, Inc. is expected to be a global leader in healthy, natural and zero-calorie foods and ingredients
Shares of
common stock and warrants of Whole Earth Brands, Inc. now trade on Nasdaq under the ticker symbols FREE and FREEW, respectively
Whole Earth
Brands, Inc. to leverage its experienced management team, strong and stable free cash flow and global footprint to accelerate growth
and capitalize on powerful consumer trends
NEW YORK & CHICAGO--Whole Earth Brands,
Inc. (NASDAQ: FREE), formerly known as Act II Global Acquisition Corp., announced today the completion of its business combination
transaction with Flavors Holdings Inc. subsidiaries Merisant Company ("Merisant"), one of the world's leading
manufacturers of calorie-FREE and low-calorie sugar substitutes, and MAFCO Worldwide LLC ("MAFCO"), the world's
leading manufacturer of natural licorice products. As of June 25, 2020, shares of common stock and warrants of Whole Earth Brands
trade on Nasdaq under the ticker symbols FREE and FREEW, respectively.
The combined business will leverage the
deep experience of its management team, global leadership in fast growing consumer packaged goods categories and an enhanced capital
structure to accelerate growth through increased innovation and distribution across its global platform.
Irwin Simon, Executive Chairman of Whole
Earth Brands commented, "I am enthusiastic about the opportunity to create Whole Earth Brands and help craft its strategy
in the industry where I spent my entire career and built powerful brands. We have created a global, industry leading platform,
focused on food products and ingredients in rapidly growing categories driven by powerful macro trends that we believe are permanently
changing the way food is consumed. We have an accomplished team capable of strengthening our leadership in our core markets as
the shift away from sugar accelerates and demand for natural ingredients intensifies. With the overwhelming support of our public
and PIPE investors, we closed the transaction at highly attractive leverage levels, giving us the flexibility to use our financial
position to accelerate organic and strategic growth in the areas that we have identified".
Albert Manzone, Chief Executive Officer
of Whole Earth Brands added "We are very pleased to complete the formation of Whole Earth Brands through this business combination.
We have two strong franchises and a significant industry tailwind. We continue to be impressed by the scaleable platform our business
offers with significant operating leverage. We now have the financial resources to expand through strategic consolidation, grow
in adjacent markets and enter into on-trend branded health and wellness categories. Our team recognizes the opportunity this transaction
has presented. We are ready to seize the moment".
Whole Earth Brands will be led by Flavors
Holdings' existing management team, including Chief Executive Officer of Flavors Holdings, Albert Manzone, who has been named
CEO of Whole Earth Brands; Chief Financial Officer of Flavors Holdings and Merisant Andy Rusie, who has been named Chief Financial
Officer of Whole Earth Brands; President of MAFCO, Lucas Bailey, who has been named President of Whole Earth Brands' Flavors
and Ingredients Division and Act II Chairman Irwin D. Simon, who will serve as Executive Chairman of Whole Earth Brands.
Following the closing, there are 35,426,669
shares of common stock outstanding
1
.
1
Excludes 3.0 million shares issued to Act II's
sponsor that will be held in escrow. For more details on the escrow terms please refer to the definitive proxy statement/prospectus
of Act II filed with the SEC.
About Whole Earth Brands
Following the closing, the combined company
will be rebranded as Whole Earth Brands. Whole Earth Brands will look to expand its branded products platform through investment
opportunities in the natural alternatives and clean label categories across the global consumer product industry. Over time, Whole
Earth Brands will look to become a portfolio of brands that Open a World of Goodness™ to consumers and their families. Whole
Earth Brands shares of common stock and warrants are listed on NASDAQ. www.wholeearthbrands.com
Forward Looking Statements
This press release includes "forward-looking
statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation
Reform Act of 1995. Forward-looking statements, such as projected financial information, may be identified by the use of words
such as "forecast", "intend", "seek", "target", "anticipate", "believe,"
"will", "expect", "estimate", "plan", "outlook", and "project"
and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters.
Such forward-looking statements include statements about our beliefs and expectations contained herein. Such forward-looking statements
with respect to strategies, prospects and other aspects of the business of Whole Earth Brands are based on current expectations
that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from
those expressed or implied by such forward-looking statements.
These factors include, but are not limited
to: (1) potential adverse effects of the ongoing global COVID-19 pandemic; (2) the ability to comply with Nasdaq listing standards
following the consummation of the business combination; (3) the ability to recognize the anticipated benefits of the business combination,
which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably,
maintain relationships with suppliers, obtain adequate supply of products and retain its management and key employees; (4) costs
related to the business combination; (5) changes in applicable laws or regulations; (6) the possibility that Whole Earth Brands
may be adversely affected by other economic, business, and/or competitive factors; (7) the inability to achieve estimates of expenses
and profitability; (8) the impact of foreign currency exchange rates and interest rate fluctuations on results; and (9) other risks
and uncertainties indicated from time to time in the definitive proxy statement/prospectus of Act II Global Acquisition Corp.,
including those under "Risk Factors" therein, and other documents filed (or furnished) or to be filed (or furnished)
with the Securities and Exchange Commission by Act II (including the supplement to the definitive proxy statement/prospectus) and
Whole Earth Brands. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the
date made. Whole Earth Brands undertakes no commitment to update or revise the forward-looking statements, whether as a result
of new information, future events or otherwise, except as required by law.
Contacts
Scott Van Winkle / Cory Ziskind
ICR
646-277-1200
scott.vanwinkle@icrinc.com; cory.ziskind@icrinc.com

text:
Whole Earth
Brands, Inc.

text:
Whole Earth
Brands, Inc.

text: Whole Earth Brands, Inc.

text:
Whole Earth
Brands, Inc.

text:
Whole Earth Brands,
Inc.

text: Flavors Holdings Inc.

text: Albert Manzone

text: Albert Manzone


text:
EX-99
2
est81-99.htm
EXHIBIT 99.1
Exhibit 99.1
Esterline Corporation
500 108th Avenue NE
Suite 1500
Bellevue, WA 98004
Tel: 425-453-9400
Fax: 425-453-2916
www.esterline.com
NYSE symbol: ESL
News
FOR IMMEDIATE RELEASE
Contact:
Brian D. Keogh
425/453-9400
ESTERLINE FINALIZES ACQUISITION OF LEACH HOLDING CORP.
BELLEVUE, Wash., August 30, 2004--Esterline Corporation (NYSE/ESL
www.esterline.com
) today announced that it has completed the acquisition of Leach Holding Corporation for approximately $145 million in cash. The transaction, announced July 9, adds nearly $120 million to Esterline's current annualized revenue base of $600 million.
Leach is a leading producer of high-performance electromechanical relays, solid-state switching devices and advanced power distribution assemblies primarily for aerospace applications. The company employs more than 1,000 people in North America, Europe and Asia. Its principal aerospace operations, which account for more than 80% of revenues, are located in southern California and France. A smaller medical device manufacturing operation is located in Germany.
Robert W. Cremin, Esterline CEO, said, "...Leach is a perfect fit with Esterline and significantly expands the tool-kit of solutions that we provide to our customers." Cremin said that aerospace switching technology is a core strength for Esterline and a niche we have been actively consolidating for many years.
With the acquisition of Leach, Esterline now employs nearly 6,000 people around the world, focused on the manufacture of specialized components for aerospace/defense and medical markets. Approximately 80% of Esterline's total revenues are generated from aerospace/defense markets; the remaining 20% is derived from the application of these technologies into other markets, most notably medical.
Cremin said that the Leach aerospace business will continue to run as a stand-alone operation reporting directly to Esterline. The German medical operation will report to Esterline's Interface Technologies Group headquartered in Coeur d'Alene, Idaho. Cremin said this latter arrangement is a timely response to customer requests for Esterline to establish manufacturing and engineering capability in Europe to support medical equipment growth overseas.
(more)
<PAGE>
About Esterline:
Esterline Corporation is a specialized manufacturing company serving principally aerospace/defense and medical markets. Esterline management views the company's businesses in three segments related to its set of core competencies: Avionics & Controls, Sensors & Systems, and Advanced Materials.
Operations within the Avionics & Controls segment focus on technology interface systems for commercial and military aircraft and similar devices for land- and sea-based military vehicles, secure communications systems, specialized medical equipment, and other high-end industrial applications. The Sensors & Systems segment includes operations that produce high-precision temperature and pressure sensors, fluid and motion control components, and other related systems principally for aerospace and defense customers. Advanced Materials focuses on process-related technologies, including high-performance elastomer products used for a wide range of military and commercial aerospace purposes and combustible ordnance and electronic warfare countermeasure products.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the current intent and expectations of the management of Esterline, are not guarantees of future performance, and involve risks and uncertainties that are difficult to predict. Esterline's actual results and the timing and outcome of events may differ materially from those expressed in or implied by the forward-looking statements due to changes in the aerospace/defense industry and other risks detailed in the company's public filings with the Securities and Exchange Commission, including the company's Annual Report on Form 10-K for the year ended October 31, 2003.
<PAGE>

text: Esterline Corporation

text: ESTERLINE

text: LEACH HOLDING CORP

text: Esterline Corporation

text: Leach Holding Corporation

text: Esterline

text: Leach

text: Esterline

text: Leach

text: Esterline

text: Esterline

text: Leach

text: Esterline

text: Esterline

text: Leach

text: Esterline

text: Esterline

text: Esterline

text: Esterline

text: Esterline Corporation

text: Esterline

text: Esterline

text: Esterline


text:
EX-99.2
16
v382279_ex99-2.htm
EXHIBIT 99.2
Cell Source Inc. Announces
Acquisition and
$3.6 Million Private
Placement to Advance Novel Cancer Therapies
TEL AVIV, ISRAEL and NEW
YORK, USA (Marketwire - July 1, 2014) Cell Source, Inc. (OTCQB: CLCS) ("Cell Source") today announced the successful
acquisition (the "Acquisition"), through a share exchange agreement, of all of the outstanding shares of Cell Source
(Israel) Ltd., a pre-clinical cell therapy development company with a focus on the facilitation of safer and more accessible bone
marrow and organ transplants and effective treatment of blood cell cancers (e.g., leukemia, lymphoma). Prior to the Acquisition,
Cell Source Ltd. completed a private placement consisting of approximately 4.8 million units of its securities, for total gross
proceeds of approximately $3.6 million. Each unit consisted of one share of common stock and one common stock purchase warrant.
Sichenzia Ross Friedman Ference LLP (www.SRFF.com) acted as legal counsel to Cell Source (Israel) Ltd. in the private placement
and Acquisition.
"Cell Source feels that
becoming a public company is an important step forward" stated Itamar Shimrat, Chief Executive Officer of Cell Source. "Becoming
a publicly traded company will allow for broad and diversified investor exposure and expanded access to capital markets. These
funds will position us to conduct human clinical trials for our proprietary cell therapy treatments". Our company and our
management are committed to creating shareholder value by commercializing exciting cell therapies addressing areas of significant
unmet medical need, particularly where patients have not responded to currently available medical options".
Cell Source is planning to
commence a Phase I/II clinical trial with a cell therapy treatment that aspires to significantly reduce the need for immune suppression
treatment for both donor-matched and "mismatched" bone marrow transplant patients. This treatment could potentially
lead to a substantial increase in patient survival rates.
Cell Source will continue
the business of Cell Source (Israel) Ltd., headquartered in Tel Aviv, Israel as a subsidiary under the leadership of Cell Source
(Israel) Ltd.'s current management team, headed by Chief Executive Officer Itamar Shimrat. In connection with the Acquisition,
Cell Source issued to the former shareholders of Cell Source (Israel) Ltd. 18,245,923 shares of its common stock. Details of the
transaction will be filed on a Form 8-K with the United States Securities and Exchange Commission.
The securities sold in the
private placement have not been registered under the Securities Act of 1933 and may not be resold absent registration under or
exemption from such Act. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities.
This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act of 1933.
About Cell Source
Cell Source Limited was founded
in 2011 to develop and commercialize preclinical cell therapy treatments which showed promising results in treating animals suffering
from blood cancers such as leukemia and lymphoma. Since then Cell Source has moved forward by both sponsoring further research
and applying for approval to conduct human clinical trials.
For further information,
please visit
www.cell-source.com
or contact Itamar Shimrat,
President & CEO (646) 416-7896
SAFE HARBOR STATEMENT UNDER
THE PRIVATE SECURITIES LITIGATION ACT OF 1995
With
the exception of historical information, the matters discussed in this news release are forward-looking statements that involve
a number of risks and uncertainties. The actual future results of Cell Source could differ significantly from those statements.
Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the
company's operations, inability to hire and retain qualified personnel, and changes in the general economic climate. In some cases,
you can identify forward-looking statements by terminology such as "may", "will", "should", "expect,"
"plan", "anticipate", "believe", "estimate", "predict", "potential"
or "continue", the negative of such terms, or other comparable terminology. These statements are only predictions. Although
we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded
as a representation by Cell Source, or any other person, that such forward-looking statements will be achieved. We undertake no
duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light
of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.
This release does not constitute an offer to sell or a solicitation
of offers to buy any securities of any entity.

text: Cell Source Inc.

text: Cell Source, Inc.

text:
Cell Source
(Israel) Ltd.

text: Sichenzia Ross Friedman Ference LLP

text: Cell Source (Israel) Ltd.

text: Itamar Shimrat

text: Cell Source (Israel) Ltd.

text:
Cell Source
(Israel) Ltd.

text: Itamar Shimrat

text: Cell Source (Israel) Ltd.

text: Itamar Shimrat


text:
EX-99
2
gpre8k070609ex991.htm
EX. 99.1 PRESS RELEASE
Exhibit 99.1
Exhibit 99.1
News Release
GREEN PLAINS RENEWABLE ENERGY, INC.
COMPLETES ACQUISITION OF NEBRASKA ETHANOL PLANTS
Green Plains Expects to Begin Operations at Plants During July
Omaha, NE (Marketwire) - July 6, 2009
- Green Plains Renewable Energy, Inc. (NASDAQ: GPRE) announces that it has completed the previously-announced acquisition of the two ethanol plants located in Nebraska. The plants located near Central City and Ord add 150 million gallons of ethanol production capacity per year, making Green Plains the fourth largest ethanol producer in the U.S. with 480 million gallons of annual expected capacity. AgStar Financial Services, PCA and certain other banks (the "Lenders") provided $123.5 million in financing for the plant acquisitions and the Lenders have supplied $16.0 million in seasonal revolving loans for working capital needs of the plants.
"We are delighted to close this transaction and look forward to bringing these plants online as soon as possible", said Todd Becker, Green Plains' President and Chief Executive Officer. "We welcome over 80 new employees to the Green Plains team".
"The broad support by Governor Heineman related to production of all forms of renewable energy was instrumental in our decision to purchase these two ethanol plants within the State of Nebraska", Becker added. "This acquisition helps support local and regional economies as well".
About Green Plains
Green Plains Renewable Energy, Inc. is a low-cost ethanol producer operating six ethanol plants in Iowa, Indiana, Nebraska and Tennessee with a combined expected operating capacity of 480 million gallons of ethanol per year. Green Plains also operates an independent third-party ethanol marketing service, with marketing capacity of 305 million gallons of ethanol per year. Green Plains owns 51% of Blendstar, LLC, a Houston-based biofuel terminal operator with six facilities in five states. Green Plains' agribusiness segment operates grain storage facilities and complementary agronomy, feed, and fuel businesses in northern Iowa and southern Minnesota.
Safe Harbor
This news release contains forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. Such statements are identified by the use of words such as "anticipate", "estimate", "expect", "will", "project", "intend", "plan", "believe", and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Such statements are based on management's current expectations and are subject to various factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such forward-looking statements. Green Plains may experience significant fluctuations in future operating results due to a number of economic conditions, including, but not limited to, competition in the ethanol industry, risks associated with commodity market risks, financial market risks, counter-party risks, risks associated with changes to federal policy and/or regulation, successful integration and profitable operation of these acquired facilities, and other risks detailed in the Company's reports filed with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the period ended December 31, 2008 and in the Company's subsequent filings with the SEC. Green Plains assumes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. The cautionary statements in this report expressly qualify all of our forward-looking statements. In addition, the Company is not obligated, and does not intend, to update any of its forward-looking statements at any time unless an update is required by applicable securities laws.
Green Plains Contact:
Green Plains
Investor Contact:
Jim Stark, Vice-President - Investor Relations
John Baldissera
Green Plains Renewable Energy, Inc.
BPC Financial Marketing
(402) 884-8700
(800) 368-1217
jim.stark@gpreinc.com

text: GREEN PLAINS RENEWABLE ENERGY, INC.

text: NEBRASKA ETHANOL PLANTS

text: Green Plains

text: Green Plains Renewable Energy, Inc.

text: Green Plains

text: Green Plains

text: Green Plains

text: Green Plains

text: Green Plains Renewable Energy, Inc.

text: Green Plains

text: Green Plains

text: Green Plains

text: Green Plains

text: Green Plains

text: Green Plains

text: Green Plains

text: Green Plains Renewable Energy, Inc.


text:
EX-99
3
exh992.txt
EXHIBIT 99.2
EXHIBIT 99.2
VALERO ENERGY CORPORATION ANNOUNCES FINAL RESULTS OF ELECTIONS FOR MERGER
CONSIDERATION
Friday September 2, 11:22 am ET
SAN ANTONIO--(BUSINESS WIRE)--Sept. 2, 2005--Valero Energy Corporation (NYSE:VLO
- News) today announced the final results of elections made by Premcor
stockholders for the form of merger consideration to be received in the merger
of Premcor and Valero, which was consummated on September 1, 2005. The results
of elections as reported to Valero by the exchange agent, Computershare Trust
Company of New York, are as follows:
CASH ELECTIONS: Elections to receive $72.76 in cash for each share of
Premcor common stock were validly made with respect to 182,530 shares
of Premcor common stock;
STOCK ELECTIONS: Elections to receive 0.99 shares of Valero common
stock for each share of Premcor common stock were validly made with
respect to 88,059,939 shares of Premcor common stock; and
NON-ELECTIONS: No election was validly made with respect to 1,069,007
shares of Premcor common stock.
The elections are subject to proration procedures as described in greater detail
on pages 41 through 45 in the proxy statement/prospectus. Based on these results
of the elections, the merger consideration expected to be paid to Premcor
stockholders is as follows:
CASH ELECTIONS: Each Premcor share with respect to which an election to
receive $72.76 in cash was validly made will receive $72.76 in cash;
STOCK ELECTIONS: Each Premcor share with respect to which an election
to receive 0.99 shares of Valero common stock was validly made will
receive 0.48233 shares of Valero common stock and $37.31 in cash; and
NON-ELECTIONS: Each Premcor share with respect to which a valid
election was not made will receive $72.76 in cash.
Fractional shares of Valero will not be issued in the merger. In lieu thereof,
stockholders will receive cash as provided in the merger agreement in an amount
equal to the value (determined with reference to the closing price of a share of
Valero common stock as reported on the NYSE Composite Tape on August 31, 2005,
the last full trading day immediately prior to the closing date) of such
fractional interest.
Valero Energy Corporation is a Fortune 500 company based in San Antonio, with
approximately 22,000 employees and annual revenue of about $70 billion. The
company owns and operates 18 refineries throughout the United States, Canada and
the Caribbean with a combined throughput capacity of approximately 3.3 million
barrels per day, making it the largest refiner in North America. Valero is also
one of the nation's largest retail operators with more than 4,700 retail
and branded wholesale outlets in the United States, Canada and the Caribbean
under various brand names including Valero, Diamond Shamrock, Shamrock,
Ultramar, and Beacon. Please visit www.valero.com for more information.
Statements contained in this press release that state the company's or
management's expectations or predictions of the future are forward-looking
statements intended to be covered by the safe harbor provisions of the
Securities Act of 1933 and the Securities Exchange Act of 1934. The words
"believe", "expect", "should", "estimates", and other similar expressions
identify forward-looking statements. It is important to note that actual results
could differ materially from those projected in such forward-looking statements.
For more information concerning factors that could cause actual results to
differ from those expressed or forecast, see the proxy statement/prospectus
dated July 13, 2005 regarding the merger of Valero and Premcor, and the amended
Form S-4 Registration Statement filed with the Securities and Exchange
Commission (as the same may be supplemented or amended). Also see both
companies' reports, including annual reports on Form 10-K and quarterly reports
on Form 10-Q, filed with the Securities and Exchange Commission and available on
the Valero web site at www.valero.com.
--------------------------------------------------------------------------------
Contact:
Valero Energy Corporation, San Antonio
Investors, Eric Fisher, Vice President,
Investor Relations: 210-345-2896
or
Media, Mary Rose Brown, Senior Vice President,
Corporate Communications: 210-345-2314
Web site: http://www.valero.com/

text: VALERO ENERGY CORPORATION

text: Valero Energy Corporation

text: Premcor

text: Premcor

text: Valero

text: Valero

text: Premcor

text: Premcor

text: Valero

text: Premcor

text: Premcor

text: Premcor

text: Premcor

text: Premcor

text: Premcor

text: Valero

text: Valero

text: Premcor

text: Valero

text: Valero

text: Valero Energy Corporation

text: Valero

text: Valero

text: Valero

text: Premcor

text: Valero

text: Valero Energy Corporation

text: Eric Fisher


text:
EX-99.4
4
exhibit3.htm
EX-99.4
EX-99.4
Exhibit 99.4
CLOSING PRESS RELEASE
AMDL Announces Closing of Jade Pharmaceutical Acquisition
Thursday September 28, 12:30 a.m. ET
TUSTIN, Calif., Sept. 28 /PRNewswire-FirstCall/ - AMDL, Inc. (Amex:
ADL
-
News
),
developer and marketer of tests for the early detection of cancer and other serious diseases,
announced today that the acquisition of Jade Pharmaceutical Inc. (JPI) and its two wholly owned
China based subsidiaries for an aggregate of 2,743,000 post-reverse split (13,715,000 pre-reverse
split) shares of AMDL Common Stock.
The JPI acquisition was closed on September 28, 2006, immediately after the filing of a Certificate
of Amendment to AMDL's Certificate of Incorporation increasing AMDL's authorized Common Stock and
reverse splitting the outstanding shares of Common Stock. The stockholders approved these proposals
at the meeting held on September 8, 2006. As a condition to the closing, Henry Jia, a director of
JPI and a principal of Jade Capital Group Ltd., the former sole stockholder of JPI, has joined
AMDL's Board of Directors.
"JPI has already filed the application for the China State Food and Drug Administration (SFDA) for
approval to market AMDL's cancer detection test DR-70® in China. There is a large market for this
test in China where cancer is a huge problem and the sort of synergy this displays is what we will
continue to perform for our shareholders", said Gary Dreher, AMDL CEO.
"This is a particularly exiting time for AMDL", said Gary Dreher, AMDL's CEO. "We are confident
that together AMDL and JPI will obtain clearance to market DR-70® from the Chinese SFDA, and we are
hopeful that the U.S. Food and Drug Administration will be impressed with the data we have
collected to support our application for clearance to market DR-70® in the United States".
About AMDL
AMDL, Inc. (Amex:
ADL
-
News
), headquartered in Tustin, California, is a
theranostics company, involved in the detection and treatment of the same disease, cancer. AMDL is
the inventor, developer and worldwide marketer through exclusive distribution agreements of the
DR-70® non-invasive cancer blood test, which has demonstrated its ability to detect the presence in
humans of up to 14 cancers 84 percent of the time overall. In a study published in the Journal of
Immunoassay (1998, vol. 19, pp 63-72) DR-70® was shown to detect at least 13 different types of
cancer (lung, breast, stomach, liver, colon, rectal, ovarian, esophageal, cervical, trophoblastic,
thyroid, malignant lymphoma, pancreatic) although the sample size for 9 of the cancers was not
statistically significant. Clinical trials of DR-70® have been conducted in Canada, China, Germany,
Taiwan and Turkey. DR-70® can detect many kinds of cancer using a single tube of blood, eliminating
the need for costly, multiple tests. AMDL also owns a combination immunogene therapy technology
that is a possible treatment for those already diagnosed with cancer and could eventually be used
as a vaccine to protect patients known to be at risk because of a family history for certain types
of cancer. The combination therapy both builds the body's immune system and destroys cancer cells.
More information about AMDL and its additional products can be obtained at
www.amdl.com
.
About Jade Pharmaceutical: JPI has two China based subsidiaries which are engaged in the research
and development of new pharmaceutical products and the manufacture and sale of prescription and
over the counter pharmaceuticals and injectables. JPI recently received approval from the China
State Food and Drug Administration to market their drug Ondansetron® (Ondansetron Hydrochloride
Injection) to treat cancer patients experiencing nausea for immediate use in hospitals and clinics
in the People's Republic of China.
Forward-Looking Statements
The Company intends that the statements in this press release that are not historical constitute
"forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as
amended and Section 21 of the Securities Exchange Act of 1934, as amended and are subject to
numerous risks and uncertainties, including the risks (i) that the transaction described may not be
completed when expected, or at all, (ii) the risk that the terms of the definitive acquisition
agreements may materially differ from that disclosed herein, (iii) the risks related to the
inability to obtain or meet conditions imposed for, governmental and other approvals of the
transaction, including the approval by the stockholders of AMDL, (iv) risks related to the
uncertainty surrounding the transaction and transactions of this type and (v) the costs related
thereto. In addition, these forward-looking statements are subject to the other risks of AMDL's
business, including, but not limited to, (a) AMDL's failure to complete successfully the
development of new or enhanced products, (b) AMDL's future capital needs, (c) the lack of market
demand for any new or enhanced products that AMDL may develop, (d) the lack of market acceptance of
AMDL's products and its limited revenues to date, (e) the success of competitive products, other
economic factors affecting AMDL and its markets, and (f) other risks detailed from time to time in
the Company's filings with the Securities and Exchange Commission. The actual results may differ
materially from those contained in this press release. The Company disclaims any obligation to
update any statements in this press release in the event of new circumstances or unanticipated
events that may occur in the future.
AMDL, Inc.
Gary L. Dreher
President & CEO
Contact (714) 505-4460

text: AMDL

text: Jade Pharmaceutical

text: AMDL, Inc.

text: Jade Pharmaceutical Inc.

text: JPI

text: AMDL

text: JPI

text: AMDL

text: AMDL

text: JPI

text: JPI

text: AMDL

text: JPI

text: AMDL

text: AMDL

text: AMDL

text: AMDL

text: AMDL

text: JPI

text: AMDL

text: AMDL, Inc.

text: AMDL

text: AMDL

text: AMDL

text: Jade Pharmaceutical

text: JPI

text: JPI

text: AMDL

text: AMDL

text: AMDL

text: AMDL

text: AMDL

text: AMDL

text: AMDL

text: AMDL, Inc.

text: Gary L. Dreher


text:
EX-99.1
6
ex99-1.htm
Zenergy
Brands Closes Acquisition of Retail Electric Provider; Enertrade Electric
DALLAS,
TX-April 9, 2018 - Zenergy Brands, Inc. (OTCQB: ZNGY), the nation's leading next-generation utility, announced
today that it has concluded its acquisition of Enertrade Electric LLC, a Texas-based Retail Electric Provider (REP) on April 3rd.
This
acquisition culminates efforts that have gone on for more than a year, and the Company is pleased to officially enter the REP
space with Enertrade as a subsidiary of Zenergy. With its management team's extensive knowledge of the deregulated energy
industry, combined with its smart controls and conservation business platforms, the Company now aspires to become a market leader
and single-source provider of retail energy sales, smart controls and responsible energy initiatives (Conservation, Green Energy
Sourcing, Demand-Response and Time-of-Use Programs).
"We
are very grateful to the executives of Enertrade for remaining patient and sticking with us as this deal did take longer to close
than we originally expected", CEO Alex Rodriguez said. "But we are so proud and excited that we now have the REP platform
to complement our smart controls and energy conservation offerings".
With
this strategic acquisition, Zenergy adds an essential complementary service to its suite of smart energy products and services,
this time a reputable, fully operating, licensed REP, thereby further increasing the firm's value proposition.
Rodriguez
added, "Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation
and retail energy to deliver the comprehensive smart energy service to customers. With this acquisition now complete, we are fully
equipped to fulfill all aspects of that mandate, which is a development that our shareholders should be excited about".
Zenergy
Chairman, Byron Young, said, "The closing on the Enertrade REP Acquisition is a major milestone for Zenergy because we believe
that the combination of the REP and Zero Cost services offered as a commercial package may create a very strong, low churn, highly
valuable book of business. Moreover, we will be able to offer traditional residential and business electricity services".
ABOUT
ZENERGY BRANDS, INC.
Zenergy
Brands, Inc. (OTCQB: ZNGY), is a next-generation energy and technology company operating in the emerging smart energy/utility
industry. The Company provides energy conservation, smart controls, and efficiency-based products and services as a fully integrated
energy company. Zenergy is a public company, fully reporting to the SEC and currently trading on the OTCQB, a venture market designed
for early-stage and developing U.S. and international companies. To learn more, visit www.zenergybrands.com.
Facebook:
Zenergy Brands
Twitter:
@ZenergyBrands
Instagram:
@ZenergyBrands
YouTube:
Zenergy Brands
FORWARD-LOOKING
STATEMENTS
This
press release may contain forward-looking statements. The words "believe", "expect", "should,"
"intend", "estimate", "projects", variations of such words and similar expressions identify
forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking
statements are based upon the Company's current expectations and are subject to some risks, uncertainties, and assumptions.
The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future
events or otherwise. Among the critical factors that could cause actual results to differ significantly from those expressed or
implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.
INVESTORS
& MEDIA CONTACT:
Email:
investors@zenergybrands.com
Phone:
(469) 228-1400
Fax:
(469) 626-5101

text:
Zenergy
Brands

text: Enertrade Electric

text: Zenergy Brands, Inc.

text: Enertrade Electric LLC

text: Zenergy

text: Zenergy

text: Zenergy

text: Zenergy

text: ZENERGY BRANDS, INC.

text:
Zenergy
Brands, Inc.

text: Zenergy

text: Zenergy Brands

text: Zenergy Brands


text:
EX-99.3
18
strc-ex993_362.htm
EX-99.3
strc-ex993_362.htm
Exhibit 99.3
Sarcos Technology and Robotics Corporation to Commence Trading on Nasdaq
Global leader in the development of highly dexterous mobile robotic systems closes business combination with Rotor Acquisition Corp.
Stock to begin trading on the Nasdaq on September 27, 2021,
under the ticker symbol "STRC"
Gross proceeds of more than $260 million from the business combination are expected to fund scale deployment of the award-winning Guardian
®
XO
®
industrial exoskeleton and Guardian
®
XT
™
industrial robotic avatar system
SALT LAKE CITY - September 27, 2021 -
Sarcos Technology and Robotics Corporation ("Sarcos"), a leader in the development of robotic systems that augment humans to enhance productivity and safety, today announced that its common stock and warrants have been approved for trading on the Nasdaq Global Market ("Nasdaq") under the ticker symbols "STRC" and "STRCW", respectively. Trading is expected to commence on Nasdaq on Monday, September 27, 2021.
On September 15, 2021, the Sarcos business combination with
Rotor Acquisition Corp.
("Rotor"), a publicly-traded special purpose acquisition company, was approved by Rotor's stockholders. Rotor's publicly traded common stock and warrants were de-listed from the New York Stock Exchange (NYSE) when the transaction closed on September 24, 2021. Sarcos believes that the capital raised from the business combination is sufficient to fund its current business plan and has no intention of raising additional capital at this time. In accordance with its contractual obligations and as previously disclosed, the company will file a registration statement covering the offer and resale of the shares issued to PIPE investors as soon as practicable.
"Having our securities listed on the Nasdaq is a crucial step for Sarcos", said Ben Wolff, chairman and CEO, Sarcos. "As a public company, we now have the resources we need to bring our award-winning Guardian
®
XO
®
industrial exoskeleton and Guardian
®
XT™ industrial robotic avatar system to market, giving companies in the U.S. and abroad a unique solution to the critical shortage of workers who are able to conduct physically demanding tasks. We are very excited to continue working towards the development of our first commercial units, which we expect will be ready for release at the end of 2022".
This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.
For more information on Sarcos and its award-winning product portfolio, please visit
www.sarcos.com
.
###
About the Transaction
Jefferies and PJT Partners acted as financial advisors to Sarcos and Wilson Sonsini Goodrich & Rosati, Professional Corporation acted as its legal counsel. Gibson, Dunn & Crutcher LLP acted as legal counsel and Credit Suisse acted as sole financial and capital markets advisor to Rotor. Credit Suisse, Jeffries, and PJT Partners acted as joint placement agents with respect to the private placement. Milbank LLP acted as legal counsel to the Special Committee of Rotor's Board of Directors, and Houlihan Lokey acted as financial advisor to the Special Committee.
About Sarcos Technology and Robotics Corporation
Sarcos Technology and Robotics Corporation is a leader in industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Leveraging more than 30 years of research and development, Sarcos' mobile robotic systems, including the Guardian
®
S, Guardian
®
GT, Guardian
®
XO
®
, and Guardian
®
XT™, are designed to revolutionize the future of work wherever physically demanding work is done. Sarcos is based in Salt Lake City, Utah. For more information, please visit
www.sarcos.com
.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27a of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, Sarcos' product roadmap, including the expected timing of commercialization or new product releases, Sarcos' plans to expand its product availability and Sarcos' use of capital, including Sarcos' ability to accomplish the initiatives outlined above. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. These statements may be preceded by, followed by, or include the words "believes", "estimates", "expects", "projects", "forecasts", "may", "will", "should", "seeks", "plans", "scheduled", "anticipates", "intends" or "continue" or similar expressions, although not all forward-looking statements contain these identifying terms. Such forward-looking statements involve risks, uncertainties, and other factors that may cause actual events, results or performance to differ materially from those indicated by such statements. These forward-looking statements are based on Sarcos' management's current expectations and beliefs, as well as a number of assumptions concerning future events. However, there can be no assurance that the events, results, or trends identified in these forward-looking statements will occur or be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made, and Sarcos is not under any obligation and expressly disclaims any obligation, to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law. Readers should carefully review the statements set forth in the reports which Rotor Acquisition Corp. ("Rotor") has filed with the U.S. Securities and Exchange Commission ("SEC"). In addition to factors previously disclosed in Rotor's reports filed with the SEC and those identified in this press release, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance: risks and uncertainties related to failure to realize the anticipated benefits of the business combination; Sarcos' ability to execute on its business strategy, develop new products and services and enhance existing products and services; ability to respond rapidly to emerging technology trends; ability to compete effectively and manage growth and costs; and other risks and uncertainties set forth in the section entitled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in Rotor's definitive proxy statement filed with the SEC on August 6, 2021 and other documents of Rotor filed with the SEC.
Press Contact:
Sarcos
Ben Mimmack
(801) 419-0438
pr@sarcos.com
ir@sarcos.com
MZ Group
Chris Tyson
Executive Vice President
MZ Group - MZ North America
(949) 491-8235
STRC@mzgroup.us

text: Sarcos

text: Rotor Acquisition Corp.

text: Sarcos

text: Sarcos

text: Sarcos

text: Rotor Acquisition Corp.

text: Sarcos

text: Sarcos

text: Ben Wolff

text: Sarcos

text: Sarcos

text: Jefferies

text: PJT Partners

text: Sarcos

text: Gibson, Dunn & Crutcher LLP

text: Credit Suisse

text: Credit Suisse

text: Jeffries

text: PJT Partners

text: Milbank LLP

text: Houlihan Lokey

text: Sarcos

text: Sarcos

text: Sarcos

text: Sarcos

text: Sarcos

text: Sarcos

text: Sarcos

text: Sarcos

text: Sarcos

text: Sarcos

text: Rotor Acquisition Corp.

text: Sarcos

text: Sarcos


text:
EX-99.1
2
tibb8k021809ex99_1.htm
PRESS RELEASE DATED 02-18-2009
tibb8k021809ex99_1.htm
FOR
IMMEDIATE RELEASE
TIB
Bank Assumes Deposits
of
Riverside Bank of the Gulf Coast from FDIC
Naples,
FL (02/17/09) --- TIB Financial Corp. (NASDAQ: TIBB), announced today that its
lead bank, TIB Bank, assumed as of the close of business on February 13, 2009,
all the deposits (excluding brokered deposits) of Riverside Bank of the Gulf
Coast from the Federal Deposit Insurance Corporation. The final
accounting resulted in the assumption of approximately $317 million of
deposits.
Riverside
Bank's nine offices reopened today, Tuesday, February 17, 2009 as branches of
TIB Bank. Deposits will continue to be insured by the FDIC up to the
limits of the law.
"Our
ability to assume their deposits should be looked upon as a very positive
event", said Thomas J Longe, Chairman and CEO of TIB Financial Corp. "Through
this transaction we have added an attractive mix of deposits with approximately
55% in NOW, checking and money market accounts. This mix of lower
cost deposits will help us fund our loan growth in all of the markets we
serve. In addition, our 35-year track record as a well capitalized,
safe and sound community banking company has only gotten stronger through this
transaction", Longe reported.
"The
assumption of the deposits of Riverside Bank increases our market presence in
Ft. Myers and Venice, while giving us the opportunity to expand into the
contiguous market of Cape Coral. This transaction also provides us
with additional funding for loan growth, the potential for new customer
relationships and will improve and increase our brand awareness throughout all
of the markets we serve".
"As
we welcome Riverside Bank customers into the TIB organization, we trust they
will find the transition to be a satisfactory experience. We have
always been committed to the financial health of our communities and this is a
critical opportunity to protect the deposits of local individuals and
businesses", stated Michael D. Carrigan, CEO and President of TIB
Bank.
About TIB Financial
Corp.
Headquartered
in Naples, Florida, TIB Financial Corp. is a growth-oriented financial services
company with approximately $1.9 billion in total assets, including the assumed
deposits, and 28 full-service banking offices throughout the Florida Keys,
Homestead, Naples, Bonita Springs, Fort Myers, Cape Coral, Nokomis and
Venice.
TIB
Financial Corp., through its wholly owned subsidiaries, TIB Bank, The Bank of
Venice and Naples Capital Advisors, Inc., serves the personal and commercial
banking, investment management and trust needs of local residents and businesses
in its market areas. The companies' experienced professionals are local
community leaders, who focus on a relationship-based approach built around
anticipating specific customer needs, providing sound advice and making timely
decisions. To learn more about TIB Bank, The Bank of Venice and Naples Capital
Advisors, Inc., visit
www.tibbank.com
,
www.bankofvenice.com
and
www.naplescapitaladvisors.com
.
For more information, contact Thomas J. Longe, Chairman and Chief Executive
Officer at 239-263-3344 or Stephen J. Gilhooly, Executive Vice President and
Chief Financial Officer at 239-659-5876.

text: TIB

text: Riverside Bank of the Gulf Coast

text: FDIC

text: TIB

text: TIB Bank

text:
Riverside Bank of the Gulf
Coast

text: Federal Deposit Insurance Corporation

text: TIB Bank

text: FDIC

text: TIB

text: TIB

text: Michael D. Carrigan

text:
TIB
Bank

text: TIB

text: TIB

text: TIB

text: TIB Bank

text: TIB Bank

text: Thomas J. Longe


text:
EX-99.1
2
rdsh_ex991.htm
PRESS RELEASE
EXHIBIT 99.1
ROADSHIPS HOLDINGS, INC.
Contact:
Roadships Holdings, Inc.
Tel:
+61 438158688
Cell:
3109947988
Email:
mnugent@roadships.us
Contact:
Click Evidence Inc.
Tel:
+1 520 498 0888
Cell:
520 288 1908
Email:
jon@klickzie.com
ROADSHIPS CLOSES ACQUISITION OF CLICK EVIDENCE
Oro Valley, ARIZONA - May 21, 2015 - Roadships Holdings Inc. (OTC-Pink: RDSH) today announced that it has closed the acquisition of Click Evidence, Inc. by issuing 1,796,571,209 shares of its common stock in exchange for all the issued and outstanding shares of Click.
The acquisition marks a further shift in the business direction of Roadships, which has been engaged in the transportation sector since 2008, but began developing software in collaboration with Click in 2014 through its subsidiary, Australia-based Polybia Studios.
Click's patent pending smartphone trustable imaging technology, which also embodies revolutionary "talk-to-the-picture" features, is aimed at worldwide consumer usage of pictures and videos for novel social networking as well as worldwide business usage of trusted smartphone pictures and videos wherever trusted imaging can play a mission critical business role.
Upon completion of the Click acquisition, Dr. Jon N. Leonard was appointed to Roadships' board of directors as its Chairman. Dr. Leonard was also appointed as the President and CEO of Roadships, replacing Micheal Nugent, who will continue as a director of the Company and will head up its operations in the short-sea and ground freight industry.
Dr. Leonard holds a Ph.D. in mathematics from the University of Arizona, a M.Sc. in engineering from U.C.L.A. and a B.A. in physics from the University of Arizona. He has been the Chairman and Chief Executive Officer at Click Evidence, Inc. since September 2002.
1
A self-described "serial innovator", Dr. Leonard started his career as the youngest scientist at the China Lake Naval Weapons Lab, where he conceived payloads for the first naval satellite experiments, and wrote the first six degrees of freedom simulator for high speed physical objects in air. He subsequently developed methods for verifying the guidance software code in the Minuteman ICBMs for Logicon, Inc. As a Chief Scientist at Hughes Aircraft, Dr. Leonard fostered advanced factory automation and neural network based automatic target recognition. Dr. Leonard's other business ventures have included development of the first office safe 3D printer, the chemistry for the first molecular switch, and disappearing e-mail technology.
After 9-11, Dr. Leonard joined Raytheon as director of counter terrorism technology, where he oversaw numerous programs applying advanced technology for anti-terrorism objectives, including MANTIS, an exploitation of advanced sensing for a soldier visioning system, INFINITE, an exploitation of carbon nanotubes (CNTs) to make arbitrarily long CNT fibers for military purposes, and WADNO, an exploitation of CNTs for covert signaling.
"This business combination was a natural progression of the work that we began with Polybia, which we intend to continue", observed Dr. Leonard, "but we believe that it will also be the catalyst for the full commercial rollout of our KlickZie software and will allow us to more rapidly add capacity to our back-end system. The transportation business will continue as an integral component of our strategic plan, and we look forward to developing the revenue prospects of that segment".
Roadships Holdings, Inc. (OTC-PINK: RDSH) is an emerging growth company engaged in the development of high-technology software solutions. Its premier product is the KlickZie system, which enables any smartphone camera to create trustable pictures and videos. In addition to its technology business, Roadships is pursuing opportunities in the short-sea and ground freight industry through its subsidiaries in the United States and Australia.
Safe Harbor Statement
Statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Risk factors that could cause actual results to differ materially from those projected in forward-looking statements include, but are not limited to, general business conditions, managing growth, and political and other business risks. All forward-looking statements are expressly qualified in their entirety by this paragraph and the risks and other factors detailed in Roadships' reports filed with the Securities and Exchange Commission. Roadships undertakes no duty to update these forward-looking statements.
2

text: ROADSHIPS

text: CLICK EVIDENCE

text: Roadships Holdings Inc.

text: Click Evidence, Inc.

text: Click

text: Roadships

text: Click

text: Click

text: Click

text: Jon N. Leonard

text: Roadships

text: Roadships

text: Click Evidence, Inc.

text: Roadships

text: Roadships

text: Roadships


text:
EX-99.1
3
c3543614c.txt
NEWS RELEASE
Exhibit 99.1
News Release
--------------------------------------------------------------------------------
Media Contacts: Erin Bacher
Ogilvy Public Relations Worldwide
erin.bacher@ogilvypr.com
404-881-2324 (office)
678-777-6378 (cell)
Stiefel Laboratories, Inc. Completes Acquisition of Connetics Corporation
Strategic combination strengthens the world's #1 independent dermatology company
Coral Gables, Fla. - December 28, 2006 - Stiefel Laboratories, Inc., the world's
largest independent pharmaceutical company specializing in dermatology,
announced today that it has completed the acquisition of Palo Alto, Calif.-based
Connetics Corporation. Effective with the close of trading on December 28, 2006,
shares of Connetics (NASDAQ: CNCT) will no longer be listed on the NASDAQ Stock
Market.
The combination of these two companies unites the innovative skin care products
and commercial capabilities of Stiefel Laboratories with the advanced therapies
and patented drug-delivery technologies of Connetics. It results in one of the
most robust and diverse dermatology product lines in the industry and reinforces
the commitment of Stiefel Laboratories to the advancement of dermatology
globally. This merger also creates one of the largest dermatology product
pipelines in the world, merging technology and development expertise to yield
significant advancements in the treatment of skin conditions.
"This deal marks a significant milestone in our company's history", said Charles
W. Stiefel, Chairman and Chief Executive Officer, Stiefel Laboratories. "With
the innovative products and cutting-edge technology Stiefel Laboratories
acquired through Connetics, we have enhanced our product portfolio and are well
on our way to reaching our goal of achieving $1 billion in product sales".
Mr. Stiefel said the company is particularly optimistic about the prospect of
applying the newly-acquired foam-based technologies to its product portfolio.
"Connetics is providing us with delivery technologies and expertise that we can
now apply to many of our existing products", said Stiefel. "Ultimately, this
will benefit dermatology patients around the world".
According to Bill Humphries, Chief Commercial Officer, Stiefel Laboratories, the
company is looking forward to several milestones in 2007.
"In addition to celebrating our 160th anniversary in 2007, we will celebrate the
grand opening of a new research and development facility in Research Triangle
Park, N.C.", said Humphries. "Stiefel Laboratories also will launch two novel
prescription products using the VersaFoam(R) technology as well as enter the
aesthetic dermatology market with Revaleskin(TM) in the coming year".
The Global Headquarters of Stiefel Laboratories will remain in Coral Gables,
Fla., and the Marketing and Sales headquarters will remain in Duluth, Ga.
-more-
About Stiefel Laboratories, Inc.
Founded in 1847, Stiefel Laboratories (a privately held company) is the world's
largest independent pharmaceutical company specializing in dermatology. The
company manufactures and markets a variety of prescription and non-prescription
dermatological products. Some of the best-known brands include Sarna(R), Duac(R)
Topical Gel, MimyX(TM) Cream, Olux(R), Brevoxyl(R)Creamy Wash, Oilatum(R),
Soriatane(R), Evoclin(R), Verdeso(TM) and Luxiq(R). Its wholly-owned global
network is comprised of more than 30 subsidiaries, including manufacturing
plants in six countries, research and development facilities on four continents
and products marketed in more than 100 countries around the world.
Stiefel Laboratories supplements its R&D efforts by aggressively seeking
acquisitions of dermatological product lines and companies around the world. To
learn more about Stiefel Laboratories, Inc., visit www.stiefel.com.
About Connetics Corporation
Prior to the acquisition by Stiefel Laboratories, Inc., Connetics was a publicly
held specialty pharmaceutical company focused on the development and
commercialization of innovative therapeutics for the dermatology market.
For more information about Connetics, please visit www.connetics.com.
# # #

text: Stiefel Laboratories, Inc.

text: Connetics Corporation

text: Stiefel Laboratories, Inc.

text: Connetics Corporation

text:
Charles
W. Stiefel

text: Bill Humphries

text: Stiefel Laboratories, Inc.

text: Stiefel Laboratories, Inc.

text: Connetics Corporation

text: Stiefel Laboratories, Inc.